How? - C&EN Global Enterprise (ACS Publications)

Publication Date: July 22, 2002. Copyright © 2002 AMERICAN CHEMICAL SOCIETY. ACS Chem. Eng. News Archives. First Page Image. Advertisements that ...
0 downloads 0 Views 331KB Size
Preclinical

IND

Phase I -> Phase II -> Phase III -• Launch

iiifiiiurii

*"?SS5?ÎV?S«* ^ ^ ' ^ ^ ' ^ y W ^ P ^ ' i T Ç C i ^ ^ p '

'How? ^fiVith a partner that helps you accelerate lead optimization and ppclinical development, and helps you take your product through launch. Hlcerca Biosciences accelerates drug development from lead optimization through product launch. We provide customized biological and chemical development services and problem solving to meet your clinical development plans and manufacturing needs. We provide parallel discovery and development from gene target to launch by using our extensive biological and chemical capabilities. In the lead discovery and optimization area, this includes medicinal chemistry, cell· free/cell-based assays, in vitro ADMET, in vivo pharmacology, metabolism and toxicology. Leads selected for preclinical development then undergo process chemistry, analytical testing and scale-up production to speed your drug to market. We can even guide you through the regulatory maze. That's why many of the world's leading biotechnology and pharmaceutical companies have partnered with us for drug development.

With Ricerca Biosciences. A PROVEN DRUG DEVELOPMENT

fttcieicaetoecletoee* 7528Aubumltoad

wiki? •*?#?

Corporate Business Development Tel: 888-763-4797 Fax: 440-357*»39 :••· Email: [email protected] Twice the Power for Developing Drugs

PARTNER.

wwvttieeiica4XnfT> wwMflÉceKaétWt·'···?'· ?$.'*:

y Ricerca

f^ Biosciences Driving drug discovery through development.